In the HT group, the mRNA gene expression of CXCL15 (p < 0.001), TNFα (p < 0.0001), IL6 (p < 0.001) and CYP1A1 (p < 0.001) was markedly enhanced relative to the untreated groups (Figure 5). The gene discussed is TNF; the disease is hematocrit.